Hospital pharmacy response to the COVID-19 pandemic: experience from a regional referral center in the United Arab Emirates. 2023

Muhammad Hammad, and Mohammad Mousa Tashtoush, and El Mutasim Ahmed El Faki, and Marwa Yousif Hajaj, and Saima Saeed Ahmed, and Amal Ahmed Darwish
Al Ain Hospital, Al Ain, United Arab Emirates. directmhd@outlook.com.

BACKGROUND The recent SARS-CoV-2 pandemic has resulted in significant morbidity and mortality worldwide. The healthcare systems, including pharmacies, faced unique challenges, such as managing  an overwhelming patient influx, clinical workforce management, transitioning to remote or online work, medication procurement and several others. The purpose of this study is to describe our hospital pharmacy's experience dealing with the COVID-19 pandemic and to present solutions to the challenges that arose. METHODS We retrospectively reviewed and consolidated strategies, interventions, and solutions that were implemented by our pharmaceutical institute in response to the challenges that arose during the COVID-19 pandemic. The study period was from March 1 to September 30, 2020. RESULTS We reviewed and organized our hospital pharmacy response to the COVID-19 pandemic into different categories. In inpatient and outpatient satisfaction surveys, physicians and patients expressed a high level of satisfaction with pharmacy services. The close collaboration between the pharmacy team and other clinicians was demonstrated through the number of pharmacist interventions, participation in the COVID-19 guidelines reviews, involvement in local and international research, and innovative solutions to inpatient and outpatient pharmacy medication management challenges. CONCLUSIONS This study highlights the crucial role that our pharmacists and pharmaceutical institute played in ensuring continuity of care during the COVID-19 pandemic. We implemented several key initiatives, innovations, and collaborations with other clinical disciplines to successfully overcome the challenges faced.

UI MeSH Term Description Entries

Related Publications

Muhammad Hammad, and Mohammad Mousa Tashtoush, and El Mutasim Ahmed El Faki, and Marwa Yousif Hajaj, and Saima Saeed Ahmed, and Amal Ahmed Darwish
April 2009, Southern med review,
Muhammad Hammad, and Mohammad Mousa Tashtoush, and El Mutasim Ahmed El Faki, and Marwa Yousif Hajaj, and Saima Saeed Ahmed, and Amal Ahmed Darwish
September 2021, Nature immunology,
Muhammad Hammad, and Mohammad Mousa Tashtoush, and El Mutasim Ahmed El Faki, and Marwa Yousif Hajaj, and Saima Saeed Ahmed, and Amal Ahmed Darwish
March 2014, American journal of pharmaceutical education,
Muhammad Hammad, and Mohammad Mousa Tashtoush, and El Mutasim Ahmed El Faki, and Marwa Yousif Hajaj, and Saima Saeed Ahmed, and Amal Ahmed Darwish
May 2021, Journal of pharmaceutical policy and practice,
Muhammad Hammad, and Mohammad Mousa Tashtoush, and El Mutasim Ahmed El Faki, and Marwa Yousif Hajaj, and Saima Saeed Ahmed, and Amal Ahmed Darwish
November 2023, Journal of medicine and life,
Muhammad Hammad, and Mohammad Mousa Tashtoush, and El Mutasim Ahmed El Faki, and Marwa Yousif Hajaj, and Saima Saeed Ahmed, and Amal Ahmed Darwish
January 2020, Skinmed,
Muhammad Hammad, and Mohammad Mousa Tashtoush, and El Mutasim Ahmed El Faki, and Marwa Yousif Hajaj, and Saima Saeed Ahmed, and Amal Ahmed Darwish
January 2021, Frontiers in public health,
Muhammad Hammad, and Mohammad Mousa Tashtoush, and El Mutasim Ahmed El Faki, and Marwa Yousif Hajaj, and Saima Saeed Ahmed, and Amal Ahmed Darwish
February 2023, AJOG global reports,
Muhammad Hammad, and Mohammad Mousa Tashtoush, and El Mutasim Ahmed El Faki, and Marwa Yousif Hajaj, and Saima Saeed Ahmed, and Amal Ahmed Darwish
March 2022, The primary care companion for CNS disorders,
Muhammad Hammad, and Mohammad Mousa Tashtoush, and El Mutasim Ahmed El Faki, and Marwa Yousif Hajaj, and Saima Saeed Ahmed, and Amal Ahmed Darwish
August 2022, Environmental challenges (Amsterdam, Netherlands),
Copied contents to your clipboard!